Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2489-2494

  Tanabe, Akiyo ^a   Naruse, Mitsuhide ^a   Takagi, Sachiko ^a   Tsuchiya, Ken ^a   Imaki, Toshihiro ^b   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; RENIN;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HOSPITAL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NORMAL VALUE; OUTPATIENT; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY;

EID: 0037968627     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021476     Document Type: Article

References (24)

1. Conn JW 1955 Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45:6-17
2. Bravo EL 2001 Medical management of primary hyperaldosteronism. Curr Hypertens Rep 3:406-409
3. Stowasser M 2001 Primary aldosteronism: rare bird or common cause of secondary hypertension? Curr Hypertens Rep 3:230-239
4. Beevers DG, Brown JJ, Ferriss JB, Fraser R, Lever AF, Robertson JI, Tree M 1976 Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism. Q J Med 45:401-410
5. Young SC, Shionoiri H, Takasaki I, Kihara M, Gotoh E 1991 Hypertensive complications in patients with primary aldosteronism: a retrospective study. Curr Ther Res 50:317-324
6. Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G 1999 Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 33:261-266
7. Sugihara N, Shimizu M, Kita Y, Shimizu K, Ino H, Miyamori I, Nakabayashi H, Takeda R 1992 Cardiac characteristics and postoperative courses in Cushing's syndrome. Am J Cardiol 69:1475-1480
8. Tanabe A, Naruse M, Naruse K, Hase M, Yoshimoto T, Tanaka M, Seki T, Demura R, Demura H 1997 Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other type of secondary hypertension. Hypertension Res 20:85-90
9. Obara T, Ito Y, Okamoto T, Kanaji Y, Yamashita T, Aiba M, Fujimoto Y 1992 Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 112:987-993
10. Gordon RD 1995 Primary aldosteronism. J Endocrinol Invest 18:495-511
11. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589-1593
12. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73:952-957
13. Rayner BL, Opie LH, Davidson JS 2002 The aldosterone/renin ratio as a screening test for primary aldosteronism. S Afr Med J 90:394-400
14. Nicholls MG, Robertson JIS 1993 Changes in renin secretion: physiological, pathophysiological, pharmacological, and epidemiological expression. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Merk; 74.1-74.12
15. Kem DC, Weinberger MH, Higgins JR, Kramer NJ, Gomez-Sanchez C, Holland OB 1978 Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab 46:552-560
16. Kem DC, Weinberger MH, Gomez-Sanchez C, Kramer NJ, Lerman R, Furuyama S, Nugent CA 1973 Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Invest 52:2272-2277
17. Irony I, Kater CE, Biglieri EG, Shackleton CH 1990 Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens 3:576-582
18. Doig JK, Lees KS, Reid JL 1993 The effect of drugs on the renin-angiotensin system in man. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Merk; 80.1-80.19
19. Johnston CI 1993 Angiotensin-converting enzyme inhibitors. In: Robertson JIS, Nicholls MG, eds, The renin-angiotensin system. London: Merk; 87.1-87.15
20. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM 1999 Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353:40
21. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young Jr WF 2002 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-2859
22. Montori VM, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST 2001 Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 76:877-882
23. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717
24. Sato A, Suzuki Y, Saruta T 1999 Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension. Hypertens Res 22:17-22